Ratings Com7

Equities

COM7

TH6678010005

Computer & Electronics Retailers

End-of-day quote Thailand S.E. 2025-07-11 5-day change 1st Jan Change
19.50 THB -2.50% Intraday chart for Com7 -4.41% -25.71%

Summary: Com7

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Highlights: Com7

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.63 for the 2025 fiscal year.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses: Com7

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.

Ratings Chart: Com7

Source: Surperformance

Fundamentals (Composite) Global Valuation (Composite) Financial estimates revisions (Composite) Capi.($)
1.44B
525M
- - 69.06M
Average 677.09M
Weighted average by Cap.
See all sector ratings
Investor (Composite)
Trader (Composite)
ESG MSCI
-

Financials

Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)

Valuation

P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield

Revisions

Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)

Business Predictability

Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes